EUVIMEDOpdag EUVIMED
Video/AudioOpen access

Development of Drug-resistant Cell Lines for Experimental Procedures

Suguru Kadomoto, Greg Shelley, Atsushi Mizokami, Evan T Keller

Journal of Visualized Experiments · 2025-08-12 · (222)

DOI: 10.3791/68957 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, published online on 2025-08-12. Written by Suguru Kadomoto and 3 co-authors. Institution: Department of Urology, University of Michigan, Ann Arbor; Department of Urology, Kanazawa University. Major MEDLINE topics: Drug Resistance, Neoplasm, Antineoplastic Agents. Cited 4 times so far (Crossref); 12 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The development of drug-resistant cell lines is essential for understanding the mechanisms of drug resistance and identifying strategies to overcome treatment failure in cancer therapy. Resistance models enable preclinical evaluation of novel compounds, repurposed drugs, and combination therapies. To generate resistant cells, parental cancer cell lines are repeatedly exposed to incrementally increasing concentrations of the target drug over several weeks. Cells that survive and proliferate at each stage are selected, expanded, and exposed to higher drug doses. The development of resistance is confirmed by quantifying and comparing the half-maximal inhibitory concentration (IC50) values between parental and resistant cells using cell viability assays and nonlinear regression analysis. Significantly increased IC50 values indicate successful adaptation to drug pressure and the development of resistance. These drug-resistant cell lines are available for comprehensive analysis, such as microarray and single-cell sequencing, as well as various in vitro or in vivo experiments. These models provide valuable tools for investigating potential therapeutic strategies to overcome drug resistance.

Subjects

MeSH terms (MEDLINE)

Drug Resistance, NeoplasmAntineoplastic AgentsHumansCell Line, TumorCell Survival

Substances

Antineoplastic Agents

Authors and institutions

  • Department of Urology, University of Michigan, Ann Arbor; Department of Urology, Kanazawa University.
  • Department of Urology, University of Michigan, Ann Arbor.
  • Department of Urology, Kanazawa University.
  • Department of Urology, University of Michigan, Ann Arbor; Biointerfaces Institute, University of Michigan, Ann Arbor; Single Cell Spatial Analysis Program, University of Michigan, Ann Arbor; etkeller@med.umich.edu.

Funding

  • NCI NIH HHS

Cite

APA

Kadomoto, S., Shelley, G., Mizokami, A., & Keller, E. T. (2025). Development of Drug-resistant Cell Lines for Experimental Procedures. Journal of Visualized Experiments. https://doi.org/10.3791/68957

Vancouver

Kadomoto S, Shelley G, Mizokami A, Keller ET. Development of Drug-resistant Cell Lines for Experimental Procedures. Journal of Visualized Experiments. 2025. doi:10.3791/68957

BibTeX
@article{Kadomoto2025,
  author = {Kadomoto, Suguru and Shelley, Greg and Mizokami, Atsushi and Keller, Evan T},
  title = {Development of Drug-resistant Cell Lines for Experimental Procedures},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  number = {222},
  doi = {10.3791/68957}
}
Start for free →